Elke Valk

发表

Correction: CTLA-4 Activation of Phosphatidylinositol 3-Kinase (PI 3-K) and Protein Kinase B (PKB/AKT) Sustains T-Cell Anergy without Cell Death

H. Schneider, E. Valk, Rufina Leung, 2009, PLoS ONE.

CTLA-4 Activation of Phosphatidylinositol 3-Kinase (PI 3-K) and Protein Kinase B (PKB/AKT) Sustains T-Cell Anergy without Cell Death

H. Schneider, E. Valk, Rufina Leung, 2008, PloS one.

High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.

M. Pfreundschuh, R. Möhle, M. Deckert, 2016, The Lancet. Haematology.

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial

J. Weis, F. Scherer, J. Finke, 2023, BMC Cancer.

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

G. Lenz, J. Panse, T. Calimeri, 2022, Blood.

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

E. Valk, F. Scherer, G. Ihorst, 2022, BMC cancer.

Rab8 Binding to Immune Cell-Specific Adaptor LAX Facilitates Formation of trans-Golgi Network-Proximal CTLA-4 Vesicles for Surface Expression

K. Inder, H. Schneider, E. Valk, 2014, Molecular and Cellular Biology.

T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor.

H. Kang, H. Schneider, E. Valk, 2006, Immunity.

CTLA-4 trafficking and surface expression.

H. Schneider, E. Valk, C. Rudd, 2008, Trends in immunology.

Adaptor SKAP-55 Binds p21ras Activating Exchange Factor RasGRP1 and Negatively Regulates the p21ras-ERK Pathway in T-Cells

K. Strebhardt, H. Schneider, E. Valk, 2008, PloS one.

CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function.

H. Schneider, E. Valk, C. Rudd, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Thiol antioxidants block the activation of antigen-presenting cells by contact sensitizers.

E. Valk, S. Zahn, J. Knop, 2003, The Journal of investigative dermatology.

Coupling of contact sensitizers to thiol groups is a key event for the activation of monocytes and monocyte-derived dendritic cells.

E. Valk, S. Zahn, J. Knop, 2003, The Journal of investigative dermatology.

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)

J. Finke, E. Valk, E. Zucca, 2016, BMC Cancer.

Activation and translocation of p38 mitogen-activated protein kinase after stimulation of monocytes with contact sensitizers.

E. Valk, S. Zahn, J. Saloga, 2002, The Journal of investigative dermatology.

JAK/STAT pathways are not involved in the direct activation of antigen-presenting cells by contact sensitizers

E. Valk, S. Zahn, J. Knop, 2002, Archives of Dermatological Research.

CTLA-4 regulation of T cell function via RAP-1-mediated adhesion.

H. Schneider, E. Valk, C. Rudd, 2006, Advances in experimental medicine and biology.